Skip to main content
logo
Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
32.41
+1.15 (3.68%)
At close: Aug 13, 2026, 4:00 PM EDT
32.50
+0.09 (0.28%)
After-hours: Aug 13, 2026, 7:34 PM EDT

Quince Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
321,86782345123380
Market Cap Growth
-63.12%126.88%82.36%1859.00%-93.93%-53.75%
Enterprise Value
13.941,867796.76389.91-67.15273.15
Last Close Price
32.416700.003740.002100.001274.8025240.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.43-52.2727.295.300.233.20
P/TBV Ratio
0.74--10.330.233.16

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/EBITDA Ratio
----1.30-
EV/EBIT Ratio
----1.29-
EV/FCF Ratio
----1.52-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.02-0.010.490.1600.00
Net Debt / Equity Ratio
-1.14-0.02-0.86-0.72-0.90-0.90
Net Debt / EBITDA Ratio
0.31-0.010.461.791.741.18
Net Debt / FCF Ratio
0.45-0.010.813.322.041.69
Quick Ratio
2.070.415.607.8429.387.51
Current Ratio
2.920.536.058.0930.557.85
Return on Equity (ROE)
373.03%2785.60%-98.33%-34.23%-47.66%-61.85%
Return on Assets (ROA)
-90.28%-58.06%-40.64%-25.31%-43.63%-55.98%
Return on Invested Capital (ROIC)
-225.51%-222.09%-411.98%-201.27%-457.47%-355.20%
Return on Capital Employed (ROCE)
-169.62%-73.74%-43.15%-26.72%-47.32%-61.97%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-42.34%-15.80%-1061.80%-11.17%-12.71%-1.86%
Total Shareholder Return
-42.34%-15.80%-1061.80%-11.17%-12.71%-1.86%
SEC Filings: 10-K · 10-Q